Zoe Merchant

Zoe Merchant

Auto-generated profile, based on publicly available information

Zoe Merchant

North West Lung Centre, Wythenshawe Hospital, Manchester University NHS Foundation Trust, Manchester, UK

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
JMJohn Moore
John Moore
ZMZoe Merchant
Zoe Merchant
KRKirsty Rowlinson
Kirsty Rowlinson
KMKaren McEwan
Karen McEwan
MEMatthew Evison
Matthew Evison
JSJames Steele
James Steele

16 August 2023 in Thorax
Verified
Journal Article
Open access
PDF file
PGPatrick Goodley
Patrick Goodley
HBHaval Balata
Haval Balata
AAAlberto Alonso
Alberto Alonso
CBChristopher Brockelsby
Christopher Brockelsby
MCMatthew Conroy
Matthew Conroy
PCPhil Crosbie
Phil Crosbie
Introduction: Although lung cancer screening is being implemented in the UK, there is uncertainty about the optimal invitation strategy. Here, we report participation in a community screening programme following a population-based invitation approach, examine factors associated with participation, and compare outcomes with hypothetical targeted invitations.Methods: Letters were sent to all individuals (age 55–80) registered with a general practice (n=35 practices) in North and East Manchester, inviting ever-smokers to attend a Lung Health Check (LHC). Attendees at higher risk (PLCOm2012NoRacescore≥1.5%) were offered two rounds of annual low-dose CT screening. Primary care recorded smoking codes (live and historical) were used to model hypothetical targeted invitation approaches for comparison.Results: Letters were sent to 35 899 individuals, 71% from the most socioeconomically deprived quintile. Estimated response rate in ever-smokers was 49%; a lower response rate was associated with younger age, male sex, and primary care recorded current smoking status (adjOR 0.55 (95% CI 0.52 to 0.58), p<0.001). 83% of eligible respondents attended an LHC (n=8887/10 708). 51% were eligible for screening (n=4540/8887) of whom 98% had a baseline scan (n=4468/4540). Screening adherence was 83% (n=3488/4199) and lung cancer detection 3.2% (n=144) over 2 rounds. Modelled targeted approaches required 32%–48% fewer invitations, identified 94.6%–99.3% individuals eligible for screening, and included 97.1%–98.6% of screen-detected lung cancers.Discussion: Using a population-based invitation strategy, in an area of high socioeconomic deprivation, is effective and may increase screening accessibility. Due to limitations in primary care records, targeted approaches should incorporate historical smoking codes and individuals with absent smoking records.

20 October 2024 in Clinical Oncology
Verified
Journal Article
Closed access
SCS. Collinson
S. Collinson
SIS. Ingram-Walpole
S. Ingram-Walpole
CJC. Jackson
C. Jackson
ASA. Soliman
A. Soliman
ACA.K.C. Chan
A.K.C. Chan
AWA.J. Wilson
A.J. Wilson

8 January 2025 in Anaesthesia
Verified
Journal Article
Closed access
JMJohn Moore
John Moore
ABAlec Beaney
Alec Beaney
LHLiam John Humphreys
Liam John Humphreys
ZMZoe Merchant
Zoe Merchant
KPKrishna Kholia Parmar
Krishna Kholia Parmar
DLDenny Zelda Hope Levett
Denny Zelda Hope Levett

23 March 2024 in British Journal of Anaesthesia
Verified
Journal Article
Closed access
AMAnna Myers
Anna Myers
RBRachael C. Barlow
Rachael C. Barlow
GBGabriele Baldini
Gabriele Baldini
ACAnna M. Campbell
Anna M. Campbell
FCFranco Carli
Franco Carli
RCRobert James Copeland
Robert James Copeland

5 May 2025 in Lung Cancer
Verified
Journal Article
Closed access
EGEwan Gourlay
Ewan Gourlay
KBKathryn Banfill
Kathryn Banfill
ZMZoe Merchant
Zoe Merchant
PGPatrick Goodley
Patrick Goodley
LBLouise Brown
Louise Brown
MEMatthew Evison
Matthew Evison